DE60221104D1 - Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose - Google Patents
Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptoseInfo
- Publication number
- DE60221104D1 DE60221104D1 DE60221104T DE60221104T DE60221104D1 DE 60221104 D1 DE60221104 D1 DE 60221104D1 DE 60221104 T DE60221104 T DE 60221104T DE 60221104 T DE60221104 T DE 60221104T DE 60221104 D1 DE60221104 D1 DE 60221104D1
- Authority
- DE
- Germany
- Prior art keywords
- fas
- mediated apoptosis
- harves
- stimulators
- substituted diaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
- C07C317/42—Y being a hetero atom
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27398801P | 2001-03-07 | 2001-03-07 | |
US273988P | 2001-03-07 | ||
US10/082,802 US6525091B2 (en) | 2001-03-07 | 2002-02-22 | Substituted diarylureas as stimulators for Fas-mediated apoptosis |
US82802 | 2002-02-22 | ||
PCT/US2002/006217 WO2002076930A2 (en) | 2001-03-07 | 2002-03-01 | Substituted diarylureas as stimulators for fas-mediated apoptosis |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60221104D1 true DE60221104D1 (de) | 2007-08-23 |
DE60221104T2 DE60221104T2 (de) | 2008-03-13 |
Family
ID=26767870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60221104T Expired - Fee Related DE60221104T2 (de) | 2001-03-07 | 2002-03-01 | Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1366021B1 (de) |
JP (1) | JP2004528311A (de) |
AT (1) | ATE366720T1 (de) |
AU (1) | AU2002306618B2 (de) |
CA (1) | CA2434020A1 (de) |
DE (1) | DE60221104T2 (de) |
ES (1) | ES2286267T3 (de) |
WO (1) | WO2002076930A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000041698A1 (en) | 1999-01-13 | 2000-07-20 | Bayer Corporation | φ-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
EP2324825A1 (de) | 2002-02-11 | 2011-05-25 | Bayer Healthcare LLC | Arylharnstoffe mit Angiogenese hemmender Aktivität |
US7645903B2 (en) | 2002-10-31 | 2010-01-12 | Ge Healthcare Bio-Sciences Ab | Use of urea variants as affinity ligands |
US8796250B2 (en) | 2003-05-20 | 2014-08-05 | Bayer Healthcare Llc | Diaryl ureas for diseases mediated by PDGFR |
BR122016015715B8 (pt) | 2003-07-23 | 2021-05-25 | Bayer Healthcare Llc | composições farmacêuticas de metilamida de ácido 4[4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenóxi)-piridina-2-carboxílico |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3214468A (en) * | 1959-08-14 | 1965-10-26 | Geigy Ag J R | Bis-(trifluoromethyl)-carbanilides |
US6093742A (en) * | 1997-06-27 | 2000-07-25 | Vertex Pharmaceuticals, Inc. | Inhibitors of p38 |
RU2247109C9 (ru) * | 1997-12-22 | 2005-06-20 | Байер Копэрейшн | Симметричные и несимметричные производные дифенилмочевины (варианты), фармацевтическая композиция, способ подавления роста опухолевых клеток, опосредованного киназой raf |
EP1042305B1 (de) * | 1997-12-22 | 2005-06-08 | Bayer Pharmaceuticals Corp. | HEMMUNG DER p38 KINASE UNTER VERWENDUNG VON SYMMETRISCHEN UND ASYMMETRISCHEN DIPHENYLHARNSTOFFEN |
ES2222705T3 (es) * | 1998-04-17 | 2005-02-01 | Parker Hughes Institute | Inhibidores btk y metodos para su identificacion y uso. |
-
2002
- 2002-03-01 EP EP02753691A patent/EP1366021B1/de not_active Expired - Lifetime
- 2002-03-01 AT AT02753691T patent/ATE366720T1/de not_active IP Right Cessation
- 2002-03-01 AU AU2002306618A patent/AU2002306618B2/en not_active Ceased
- 2002-03-01 CA CA002434020A patent/CA2434020A1/en not_active Abandoned
- 2002-03-01 ES ES02753691T patent/ES2286267T3/es not_active Expired - Lifetime
- 2002-03-01 DE DE60221104T patent/DE60221104T2/de not_active Expired - Fee Related
- 2002-03-01 WO PCT/US2002/006217 patent/WO2002076930A2/en active IP Right Grant
- 2002-03-01 JP JP2002576193A patent/JP2004528311A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1366021B1 (de) | 2007-07-11 |
WO2002076930A2 (en) | 2002-10-03 |
JP2004528311A (ja) | 2004-09-16 |
EP1366021A2 (de) | 2003-12-03 |
CA2434020A1 (en) | 2002-10-03 |
DE60221104T2 (de) | 2008-03-13 |
ATE366720T1 (de) | 2007-08-15 |
ES2286267T3 (es) | 2007-12-01 |
WO2002076930A3 (en) | 2003-01-16 |
AU2002306618B2 (en) | 2006-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20093464L (no) | Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika | |
ATE411022T1 (de) | Pyridylpyrrol-derivate als wirksame kinase-hemmer | |
TNSN06034A1 (en) | Pyridazine derivatives and their use as therapeutic agents | |
TNSN06032A1 (en) | Pyridazine derivatives and their use as therapeutic agents | |
ATE408601T1 (de) | Fredericamycin-derivate | |
DK1346041T3 (da) | Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom | |
ATE538103T1 (de) | Chinazolinonverbindungen als antikrebsmittel | |
EA200501849A1 (ru) | Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ | |
IL175158A0 (en) | Tocopherol-modified therapeutic drug compounds | |
BG108269A (en) | Pyrazolopyrimidines as therapeutic agents | |
HK1095138A1 (en) | Azabicyclic heterocycles as cannabinoid receptor modulators | |
IL189900A0 (en) | Mek and methods of their use | |
ATE442142T1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
MXPA04005156A (es) | Antagonistas del receptor de adenosina a2a. | |
SE9900961D0 (sv) | Novel compounds | |
ATE236147T1 (de) | Derivate von flavonen, xanthonen und kumarinen | |
SE9802208D0 (sv) | Novel compounds | |
HUP0103078A2 (hu) | Készítmények és eljárások szürkehályog kezelésére | |
ATE357438T1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
ATE396986T1 (de) | Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken | |
MXPA01008993A (es) | Tratamiento de combinacion para depresion y ansiedad. | |
EP1453507A4 (de) | Solubilisierte topoisomerase-gift-mittel | |
MXPA06007007A (es) | Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores. | |
DE60221104D1 (de) | Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose | |
SE9802209D0 (sv) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |